000			01684 a2200493 4500
005			20250514001708.0
264		0	_c20010621
008			200106s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aFeldkamp, M M
245	0	0	_aIsotype-specific Ras.GTP-levels predict the efficacy of farnesyl transferase inhibitors against human astrocytomas regardless of Ras mutational status. _h[electronic resource]
260			_bCancer research _cJun 2001
300			_a4425-31 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAlkyl and Aryl Transferases _xantagonists & inhibitors
650	0	4	_aAnimals
650	0	4	_aAstrocytoma _xdrug therapy
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aCell Division _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFarnesyltranstransferase
650	0	4	_aGenes, ras _xgenetics
650	0	4	_aGlioblastoma _xdrug therapy
650	0	4	_aGuanosine Triphosphate _xmetabolism
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred NOD
650	0	4	_aMice, Nude
650	0	4	_aMice, SCID
650	0	4	_aMonomeric GTP-Binding Proteins _xmetabolism
650	0	4	_aMutation
650	0	4	_aPiperidines _xpharmacology
650	0	4	_aPyridines _xpharmacology
650	0	4	_aTumor Cells, Cultured
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aras Proteins _xgenetics
700	1		_aLau, N
700	1		_aRoncari, L
700	1		_aGuha, A
773	0		_tCancer research _gvol. 61 _gno. 11 _gp. 4425-31
999			_c11319930 _d11319930